FIELD: biotechnology.
SUBSTANCE: application of 4-(3-ethoxy-4-hydroxybenzyl)-5-oxo-5,6-dihydro-4H-[1,3,4]-thiadiazine-2-(2,4-difluorophenyl)-carboxamide for suppression of an infection caused by antibiotic-resistant strains of Pseudomonas aeruginosa in the living body, as well as a method of suppression of the infection caused by antibiotic-resistant strains of Pseudomonas aeruginosa when exposed to Pseudomonas aeruginosa strains with an effective amount of this compound.
EFFECT: implementation of the claimed prescription for infection of mice with the indicated clinical strains genotypes, regardless of the acquired resistance, the compound does not have a bactericidal effect on the intestinal microflora of animals and is low-toxic.
2 cl, 3 dwg, 25 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| SOLID DISPERSION of 4- (3-ETHOXY-4-HYDROXIBENZIL) -5-OXO-5,6-DIHYDRO-4H- [1,3,4] -THIADIAZINE-2- (2,4-DIFLUOROPHENYL) -CARBOXAMIDE FOR PRODUCING PHARMACEUTICAL FORMULATION AND METHOD OF TREATMENT OF CHRONIC INFECTIOUS DISEASES | 2020 | 
 | RU2743927C1 | 
| METHOD FOR PRODUCTION OF POLYMORPHOUS FORM OF 4-(3-ETHOXY-4-HYDROXYBENZYL)-N-(2,4-DIFLUORPHENYL)-5-OXO-5,6-DIHYDRO-4H-1,3,4-THIADIZINE-2-CARBOXAMIDE | 2022 | 
 | RU2785195C1 | 
| PHARMACEUTICAL COMPOSITION OF 4-(3-ETHOXY-4-HYDROXYBENZYL)-5-OXO-5,6-DIHYDRO-4H-[1,3,4]-THIADIAZIN-2-(2,4-DIFLUOROPHENYL) CARBOXAMIDE IN CRYSTALLINE FORM , AND USE THEREOF AS ANTIBACTERIAL AGENT FOR TREATING ACUTE, RECURRENT AND CHRONIC INFECTIONS | 2020 | 
 | RU2737087C1 | 
| BIOLOGICALLY ACTIVE SUBSTANCES SUPPRESSING PATHOGENIC BACTERIA, AND METHOD FOR INHIBITING TYPE III SECRETION IN PATHOGENIC BACTERIA | 2012 | 
 | RU2495036C1 | 
| PATHOGENIC BACTERIA-INHIBITING BIOLOGICALLY ACTIVE SUBSTANCES AND METHOD OF INHIBITING PATHOGENIC BACTERIA TYPE III SECRETION | 2010 | 
 | RU2447066C2 | 
| METHOD FOR SIMULATING AN INTRA-ABDOMINAL PSEUDOMONAS INFECTION PROCESS | 2019 | 
 | RU2725136C1 | 
| METHODS OF COMBINED THERAPY USING BINDING MATERIALS WITH PSL AND PCRV PSEUDOMONAS | 2012 | 
 | RU2687588C2 | 
| 1-CYCLOPROPYL -6- NITRO -7- (4- METHYLPIPERAZINYL) -4-OXO- 1,4-DIHYDROQUINOLINE -3- CARBOXYLIC ACID HYDROCHLORIDE SHOWING ANTIBACTERIAL ACTIVITY | 1988 | 
 | SU1545546A1 | 
| BETA-HAIRPIN PEPTIDE WITH ANTIMICROBIAL ACTIVITY AGAINST MULTIDRUG-RESISTANT BACTERIA | 2023 | 
 | RU2812977C1 | 
| DRUG FOR TREATMENT OF BACTERIAL INFECTIONS | 2019 | 
 | RU2778521C2 | 
Authors
Dates
2017-07-07—Published
2016-10-10—Filed